𝛼SK or Search

ENTITY

Glenmark Pharmaceuticals (GNP IN)

183

Analysis

Health Care • India

Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company that develops, manufactures, and markets branded and generic formulations, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products. The company focuses on therapeutic areas including respiratory, dermatology, and oncology, with products such as Ryaltris, Winlevi, and Candid. It was founded in 1977 and is headquartered in Mumbai, India.

more

Refresh

Exchange Announcement • 17 Jul 2024 11:24

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Exchange Announcement • 10 Jul 2024 20:52

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Offer for Sale

Exchange Announcement • 10 Jul 2024 18:15

GLENMARK PHARMACEUTICALS LTD. - 532296 - Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Exchange Announcement • 12 Jun 2024 11:30

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Exchange Announcement • 04 Jun 2024 21:04

GLENMARK PHARMACEUTICALS LTD. - 532296 - Transcript Of Investor Day 2024

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x